Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 28, 2008; 14(16): 2544-2549
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2544
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2544
Table 1 Medications taken by patients at time of infliximab treatment
| Medication | UC patients (n = 15) |
| 5-ASA | |
| Current | 93.3% (14/15) |
| Intolerant | 6.7% (1/15) |
| Steroids | |
| IV | 40.0% (6/15) |
| PO | 53.3% (8/15) |
| Intolerant | 6.7% (1/15) |
| Immunomodulators | |
| AZA/6MP | 86.7% (13/15) |
| < 8 wk | 53.3% (8/15) |
| ≥ 8 wk | 33.3% (5/15) |
| Intolerant | 13.3% (2/15) |
| Tacrolimus | 6.7% (1/15) |
| Methotrexate | 6.7% (1/15) |
- Citation: Willert RP, Lawrance IC. Use of infliximab in the prevention and delay of colectomy in severe steroid dependant and refractory ulcerative colitis. World J Gastroenterol 2008; 14(16): 2544-2549
- URL: https://www.wjgnet.com/1007-9327/full/v14/i16/2544.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.2544